Cynara scolymus for relieving on nonalcoholic steatohepatitis induced in rats

International Journal of Pharmacy and Pharmaceutical Sciences

Volumn 5, Issue SUPPL.1, 2013, Pages 57-66

  Mohamed, Safaa H ^a   Ahmed, Hanaa H ^a   Farrag, Abdel Razik H ^a   Abdel Azim, Nahla S ^a   Shahat, Abdelaaty A ^a,b  

^a NATIONAL RESEARCH CENTRE   (Egypt)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Cynara scolymus; Hyperlipidemia; Inflammation; Insulin resistance; Nonalcoholic steatohepatitis; Rats

Indexed keywords

ADIPONECTIN; ALANINE AMINOTRANSFERASE; CD40 ANTIGEN; CHOLESTEROL; CYCLOOXYGENASE 2; CYNARA SCOLYMUS EXTRACT; HIGH DENSITY LIPOPROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LEPTIN; LOW DENSITY LIPOPROTEIN; METHANOL; RESISTIN; SCATTER FACTOR; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICHOKE; ARTICLE; BLOOD SAMPLING; CHEMICAL ANALYSIS; COLORIMETRY; COLUMN CHROMATOGRAPHY; CONTROLLED STUDY; DRUG EFFICACY; ELISA KIT; FEMALE; HISTOPATHOLOGY; LIPID DIET; LIVER HISTOLOGY; LIVER PROTECTION; NONALCOHOLIC FATTY LIVER; NONHUMAN; RAT;

EID: 84875452465     PISSN: None     EISSN: 09751491     Source Type: Journal    
DOI: None     Document Type: Article

References (76)

1. Paschos P, Paletas K Non-alcoholic Fatty Liver Disease and Metabolic Syndrome. Hippokratia 2009; 1: 9-19.
2. Brunt ME Non-alcoholic Steatohepatitis: Definition and Pathology. Semin Liver Dis 2001; 21: 3-16
3. Fassio E, Alvarez E, Dominguez N, Landeira G, Longo C Natural History of Non-alcoholic Steatohepatitis: a Longitudinal Study of Repeat Liver Biopsies. Hepatolology 2004; 40: 820-26.
4. Preiss D, Sattar N Non-alcoholic Fatty Liver Disease: an Overview of Prevalence, Diagnosis, Pathogenesis and Treatment Considerations. Clinical Science 2008; 115: 141-50.
5. Hůlek P, Dresslerová I Metabolic Syndrome and Liver (NAFLD/NASH). Vnitr Lek 2009; 55: 646-9.
6. Mulinacci N, Prucher D, Peruzzi M, Romani A, Pinelli P, Giaccherini C, Vincieri FF Commercial and Laboratory Extracts from Artichoke Leaves: Estimation of Caffeoyl Esters and Flavonoidic Compounds Content. Journal of Pharmaceutical and Biomedical Analysis 2004; 34: 349-57.
7. nd ed. New York: John Wiley & Sons, Inc. 1996; 4244.
8. Newall CA, Anderson LA, Phillipson JD Herbal Medicines: A Guide for Health-Care Professionals. London: The Pharmaceutical Press. 1996; 3738.
9. Speroni E, Cervellati R, Govoni P, Guizzardi S, Renzulli C, Guerra MC Efficiency of Different Cynara Scolymus Preparations Liver Complaints. J Ethnopharmacol 2003; 86: 203-11.
10. Zhu X, Zhang H, Lo R Phenolic Compounds from the Leaf Extract of Artichoke (Cynara Scolymus) and Their Antimicrobial Activities. J Agric Food Chem 2004; 52: 7272-78.
11. Küskü-Kiraz Z, Mehmetçik G, Dogru-Abbasoglu S, Uysal M Artichoke Leaf Extract Reduces Oxidative Stress and Lipoprotein Dyshomeostasis in Rats Fed on High Cholesterol Diet. Phytother Res 2010; 24: 565-70.
12. Zapolska-Downar D, Zapolski-Downar A, Naruszewicz M, Siennicka A, Krasnodebska B, Kolodziej B Protective Properties of Artichoke (Cynara Scolymus) against Oxidative Stress Induced in Cultured Endothelial Cells and Monocytes. Life Science 2002; 71: 2897-908.
13. Jimenez-Escrig A, Dragsted LO, Daneshvar B, Pulido R, Saura-Calixto F Invitro Antioxidant Activities of Edible Artichoke (Cynara Scolymus L.) and Effect on Biomarkers of Antioxidants in Rats. J Agric Food Chem 2003; 51: 5540-45.
14. Tipoe GL, Ho CT, Liong EC, Leung TM, Lau TYH, Fung ML, Nanji AA Voluntary Oral Feeding of Rats not Requiring a Very High Fat Diet is a Clinically Relevant Animal Model of Non-alcoholic Fatty Liver Disease (NAFLD). Histol Histopathol 2009; 24: 1161-69.
15. Reeves PG, Nielsen FH, Fahey GC AIN-93 Purified Diets for Laboratory Rodents: Final Report of The American Institution Ad Hoc. Writing Committee on The Reformulation of The AIN-76A Rodent diet. J Nutr 1993; 123: 1939-51.
16. Sandford HS Method for Obtaining Venous Blood from The Orbital Sinus of The Rat or Mouse. Science 1954; 119: 100.
17. Reitman S, Frankel S a Colorimetric Method for The Determination of Serum Glutamic Oxalacetic and Glutamic Pyruvic Transaminases. Am J Clin Path 1957; 28: 56-63.
18. Allain CC, Poon LS, Chan CS, Richmond W, Fu PC Enzymztic Determination of Total Serum Cholesterol. Clin Chem 1974; 20: 470-75.
19. Assman G, Jabs HU, Kohnert U, Nolte W, Schriewer H LDL-Cholesterol Determination in Blood Serum following Precipitation of LDL with Polyvinylsulfate. Clin Chim Acta 1984; 140: 77-83.
20. Lopez-Virella MF, Stone P, Elli S, Golwell JA Cholesterol Determination in HDL-Chol Separated by Three Different Methods. Clin Chem 1977; 23: 882-84.
21. Fassati P, Prencipe L Serum Triglycerides Determined Colorimetrically with an Enzyme That Produces Hydrogen Peroxide. Clin Chem 1982; 28: 2077-80.
22. Pannacciulli N, Vettor R, Milan G, Granzotto M, Catucci A, Federspil G, De Giacomo P, Giorgino R, De Pergola G Anorexia Nervosa is Characterized by Increased Adiponectin Plasma Levels and Reduced Non-oxidative Glucose Metabolism. J Clin Endocrinol Metab 2003; 88: 1748-52.
23. Petridou E, Mantzoros CS, Belechri M, Skalkidou A, Dessypris N, Papathoma E, Salvanos H, Lee JH, Kedikoglou S, Chrousos G, Trichopoulos D Neonatal Leptin Levels are Strongly Associated with Female Gender, Birth Length, IGF-I Levels and Formula Feeding. Clin Endocrinol (Oxf) 2005; 62: 366-71.
24. Schäffler A, Büchler C, Müller-Ladner U, Herfarth H, Ehling A, Paul G, Schölmerich J, Zietz B Identification of Variables Influencing Resistin Serum Levels in Patients with Type 1 and Type 2 Diabetes Mellitus. Horm Metab Res 2004; 36: 702-7.
25. Brouckaert P, Libert C, Everaerdt B, Takahashi N, Cauwels A, Fiers W Tumor Necrosis Factor-α Its Receptors and The Connection with Interleukin-1 and Interleukin-6. Immunobiology 1993; 187: 317-29.
26. Plum L, Lin HV, Dutia R, Tanaka J, Aizawa KS The Obesity Susceptibility Gene Carboxypeptidase E Links FoxO1 Signaling in Hypothalamic Pro-opiomelanocortin Neurons with Regulation of Food Intake. Nature Med 2009; 15: 1195-201.
27. nd Ed. Blockwell Significant Publication, Oxford 1987; 186.
28. Hooper AJ, Adams LA, Burnett JR Genetic Determinants of Hepatic Steatosis in Man. J Lipid Res 2011; 52: 593-617
29. Yang RZ, Park S, Reagan WJ, Goldstein R, Zhong S, Lawton M, Rajamohan F, Qian K, Liu L, Gong DW Alanine Aminotransferase Isoenzymes: Molecular Cloning and Quantitative Analysis of Tissue Expression in Rats and Serum Elevation in Liver Toxicity. Hepatology 2009; 49: 598-607.
30. Jacobs M, van Greevenbroek MM, van der Kallen CJ, Ferreira I, Feskens EJ, Jansen EH, Schalkwijk CG, Stehouwer C The Association between The Metabolic Syndrome and Alanine Amino Transferase is Mediated by Insulin Resistance via Related Metabolic Intermediates. Metabolism 2011; 60: 969-75.
31. Mehmetçik G, Ozdemirler G, Koçak-Toker N, Cevikbaş U, Uysal M Effect of Pretreatment with Artichoke Extract on Carbon Tetrachloride Induced Liver Injury and Oxidative Stress. Exp Toxicol Pathol 2008; 60: 475-80.
32. Adams LA, Lymp JF, St Sauver J, Sanderson SO, Lindor KD, Feldstein A, Angulo P The Natural History of Non-alcoholic Fatty Liver Disease: Population Based Cohort Study. Gastroenterology 2005; 129: 113-21.
33. Simonen P, Kotronen A, Hallikainen M, Sevastianova K, Makkonen J, Hakkarainen A, Lundbom N, Miettinen TA, Gylling H, Yki-Järvinen H Cholesterol Synthesis is Increased and Absorption Decreased in Non-alcoholic Fatty Liver Disease Independent of Obesity. Journal of Hepatology 2010; 54: 153-9.
34. Brown MS, Goldstein JL The SREBP Pathway: Regulation of Cholesterol Metabolism by Proteolysis of Membrane Bound Transcription Factor. Cell 1997; 89: 331-40.
35. Ikonen E Cellular Cholesterol Trafficking and Compartmentalization. Nat Rev Mol Cell Biol. 2008; 9: 125-38.
36. Caballero F, Fernandez A, De Lacy AM, Fernandez-Checa JC, Caballeria J, Garcia-Ruiz C Enhanced Free Cholesterol SREBP-2 and StAR Expression in Human NASH. J Hepatolology 2009; 50: 789-96
37. Tacer FK, Rozman D Non-alcoholic Fatty Liver Disease: Focus on Lipoprotein and Lipid Deregulation. J Lipids 2011; 2011: 783976.
38. Yki-Järvinen H Fat in The Liver and Insulin Resistance. Ann Med 2005; 37: 347-56.
39. Fromenty B, Pessayre D Inhibition of Mitochondrial Beta-oxidation as Mechanism of Hepatotoxicity. Pharmacolology Therapy1995; 67: 101-54.
40. Tsochatzis EA, Papatheodoridis GV, Archimandritis AJ Adipokines in Non-alcoholic Steatohepatitis: from Pathogensis to Implications in Diagnosis and Therapy. Mediators of inflammation 2009
41. Tulenko N, Sumner AE The Physiology of Lipoproteins. Journal of Nuclear Cardiology 2002; 9: 638-49.
42. Brown S, Goldstein JL A receptor-mediated Pathway for Cholesterol Homeostasis. Science 1986; 232: 34-47.
43. LattanzioV, Kroon PA, Linsalata V, Cardinali A Globe artichoke: A Functional Food and Source of Nutraceutical Ingredients. Journal of Functional Foods 2009; 1: 131-44.
44. Daniel M Herbal Tonic Therapies Ed. Keats Publishing, USA, 1993.
45. Gebhardt R Inhibition of Cholesterol Biosynthesis in HepG2 Cells by Artichoke Extracts is Reinforced by Glucosidase Pretreatment. Phytotherapy Research 2002; 368-72.
46. Cieslik E, Kopec A, Praznik W Healthy Properties of Jerusalem Artichoke Flour (Helianthus Tuberosus L.). El. J. Polish Agric. Univ., Food Sci. Technol., vol. 8/2/art-37, 2005; www. ejpau. media. pl/volume8/issue2/art-37. html.
47. Taylor L Tropical Plants The Healing Power of Rainforest Herbs; Garden City Park, NY: Square One Publishers 2005. ISBN 0-7570-0144-0
48. Gebhardf R Inhibition of Cholesterol Biosynthesis in Primary Culture Rat Hepatocytes by Artichoke (Cynava Scolymnus L.,) Extracts. J pharmacolology Exp Therapy 1998; 286: 3.
49. Gebhardt R Antioxidative and Protective Properties of Extract from Leaves of The Artichoke (Cynara Scolymnus L.) against Hydro-Peroxids Induced Oxidative Stress in Cultured rat Hepatocytes. Toxicol Appl pharmacol 1997; 144: 279-86.
50. Pagano C, Soardo G, Pilon C, Milocco C, Basan L, Milan G, Donnini D, Faggian D, Mussap M, Plebani M, Avellini C, Federspil G, Sechi LA, Vettor R Increased Serum Resistin in Non-alcoholic Fatty Liver Disease is Related to Liver Disease Severity and not to Insulin Resistance. J Clin Endocrinol Metab 2006; 91: 1081-6.
51. Lewis GF, Carpentier A, Adeli K, Giacca A Disordered Fat Storage and Mobilization in The Pathogenesis of Insulin Resistance and Type 2 Diabetes. Endocr Rev 2002; 23: 201-29
52. Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, Nakayama O, Makishima M, Matsuda M, Shimomura L Increased Oxidative Stress in Obesity and Its Impact on Metabolic Syndrome. J Clin Invest 2004; 114: 1752-61.
53. Joy JF, Haber SL Clinical Uses of Artichoke Leaf Extract. Am J Health Syst Ph 2007; 64: 1906-9.
54. Friedman JM Leptin Receptors, and The Control of Body Weight. Nutr Rev 1998; 56: 38-46.
55. Margetic S, Gazzola C, Pegg GG, Hill RA Leptin: Review of Its Peripheral Actions and Interactions. Int J Obes Relat Metab Disord 2002; 26: 1407-33.
56. Clark JM, Brancati FL, Diehl AM The Prevalence and Etiology of Elevated Aminotransferase Levels in the United States. Am J Gastroenterol 2003; 98: 960-7.
57. Cho AS, Jeon SM, Kim MJ, Yeo J, Seo K, Choi MS, Lee MK Chlorogenic Acid Exhibits Anti-obesity Property and Improves Lipid Metabolism in High-Fat Diet-Induced-Obese Mice. Food and Chemical Toxicology 2010; 48: 937-43.
58. Pagano C, Soardo G, Pilon C, Milocco C, Basan L, Milan G, Donnini D, Faggian D, Mussap M, Plebani M, Avellini C, Federspi, G, Sechi LA, Vettor R Increased Serum Resistin in Non-alcoholic Fatty Liver Disease is Related to Liver Disease Severity and not to Insulin Resistance. J Clin Endocrinol Metab 2006; 91: 1081-6.
59. Bajaj M, Suraamornkul S, Hardies LJ, Pratipanawatr T, DeFronzo RA Plasma Resistin Concentration, Hepatic Fat Content, and Hepatic and Peripheral Insulin Resistance in Pioglitazone-Treated Type II Diabetic Patients. Int J Obes Relat Metab Disord 2004; 28: 783-9.
60. Murad A, Hassan H, Husein H, Ayad A Serum Resistin Levels in Non-alcoholic Fatty Liver Disease and Their Relationship to Severity of Liver Disease. Journal of Endocrinology 2010; 15: 53-6.
61. 2-Induced Oxidative Stress in Human Lymphocytes. Food Chemistry 2005; 93: 653-66.
62. Baeuerle PA, Henkel T Function and Activation of NF-kappa B in The Immune System. Ann Rev Immunol 1994; 12: 141
63. Tian N, Moore RS, Braddy S, Rose RA, Gu JW, Hughson MD, Manning Jr, RD Interactions between Oxidative Stress and Inflammation in Salt-Sensitive Hypertension. Am J Physiol Heart Circ Physiol 2007; 293: 3388-95.
64. Manna SK, Mukhopadhyay A, Van NT, Aggarwal BB Silymarin Suppresses TNF-Induced Activation of NF-κB, c-Jun N-Terminal Kinase, and Apoptosis. Journal of Immunology 1999; 163: 6800-9.
65. Wigg AJ, Roberts-Thomson IC, Dymock RB, McCarthy PJ, Grose RH, Cummins AG The Role of Small Intestinal Bacterial Overgrowth, Intestinal Permeability, Endotoxaemia, and Tumor Necrosis Factor α in The Pathogenesis of Non-alcoholic Steatohepatitis. Gut 2001; 48: 206-11.
66. Ruiz AG, Casafont F, Crespo J, Cayón A, Mayorga M, Estebanez A, Fernadez-Escalante JC, Pons-Romero F Lipopolysaccharide Binding Protein Plasma Levels and Liver TNF-alpha Gene Expression in Obese Patients: Evidence for The Potential Role of Endotoxin in The Pathogenesis of Non-alcoholic Steatohepatitis. Obes Surg 2007; 17: 1374-80.
67. Kotanidou A, Xagorari A, Bagli E, Kitsanta P, Fotsis T, Papapetropoulos A, Roussos C Luteolin Reduces Lipopolysaccharide-induced Lethal Toxicity and Expression of Proinflammatory Molecules in Mice. Am J Respir Crit Care Med 2002; 65: 818-23.
68. Yu J, Ip E, dela Pec na A, Hou JY, Sesha J, Pera N, Hall P, Kirsch R, Leclercq I, Farrell JC Steatohepatitis: Role as Pro-inflammatory Mediator. Hepatology 2006; 43: 826-36.
69. Lee YS, Song YS, Giffard RG, Chan PH Biphasic Role of Nuclear Factor-kappa B on Cell Survival and COX-2 Expression in SOD1 Tg Astrocytes after Oxygen Glucose Deprivation. J Cereb Blood Flow Metab 2006; 26: 1076-88.
70. Ercin CN, Dogru T, Tapan S, Karslioglu Y, Haymana C, Kilic S, Sonmez A, Yesilova Z, Uygun A, Gulsen M, Bagci S, Erbil MK Levels of Soluble CD40 Ligand and P-Selectin in Non-alcoholic Fatty Liver Disease. Dig Dis Sci 2010; 55: 1128-34.
71. Desideri G, Fer C Effects of Obesity and Weight Loss on Soluble CD40L Levels. JAMA 2003; 289: 1781-82.
72. Unek IT, Bayraktar F, Solmaz D, Ellidokuz H, Sisman AR, Yuksel F, Yesil S The Levels of Soluble CD40 Ligand and C-Reactive Protein in Normal Weight, Overweight and Obese People. Clinical Medicine and Research 2005; 8: 89-95.
73. Pignatelli P, Cangemi R, Celestini A, Carnevale R, Polimeni L, Martini A, Ferro D, Loffredo L, Violi F. Tumor Necrosis Factor-α Upregulates Platelet CD40L in Patients With Heart Failure. Cardiovasc Cardiovasc Res 2008; 78: 515 74.
74. Hirano T, Arimitsu J, Higa S, NakaT, Ogata A, Shima Y, Fujimoto M, Yamadori T, OhkawaraT, Kuwabara Y, Kawai M, Kawase I, Tanaka T Luteolin, a Flavonoid, Inhibits CD40 Ligand Expression by Activated Human Basophils. Int Arch Allergy Immunol 2006; 140: 150.
75. Koutsogiannis D, Summers K, George B, Adams P, Marotta P, Chakrabarti S Identification of Serum Biomarkers in End Stage Liver Disease. The Open Biomarkers Journal 2010; 3: 1-6.
76. Fausto N, Laird AD, Webber EM Role of Growth Factors and Cytokines in Hepatic Regeneration. FASEB J 1995; 9: 1527-36.